Reaction
Anaplastic Large-Cell Lymphoma reporting signals
As of the last recalculation, Anaplastic Large-Cell Lymphoma appears in 236 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is BRENTUXIMAB VEDOTIN (PRR 1,163.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Brentuximab Vedotin | 86 | 1,163.7 | 1,173.6 |
| Doxorubicin Hydrochloride | 16 | 46.3 | 46.3 |
| Doxorubicin | 39 | 46.0 | 46.1 |